A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001)

Description

The goal of this study is to learn whether a new vaccine, V330, is safe and learn how well the body's immune system responds by making antibodies after receiving V330.

Conditions

Healthy

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this study is to learn whether a new vaccine, V330, is safe and learn how well the body's immune system responds by making antibodies after receiving V330.

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older Participants (60 to 79 Years Inclusive).

A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001)

Condition
Healthy
Intervention / Treatment

-

Contacts and Locations

Glendale

California Clinical Trials Medical Group managed by PAREXEL (Site 0002), Glendale, California, United States, 91206

Hallandale Beach

Velocity Clinical Research, Hallandale Beach (Site 0003), Hallandale Beach, Florida, United States, 33009

Hollywood

Research Centers of America (Hollywood ) (Site 0004(, Hollywood, Florida, United States, 33024

South Miami

QPS-MRA, LLC-Early Phase (Site 0006), South Miami, Florida, United States, 33143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Is in good health prior to randomization
  • * Is an individual from 18 to 49 years of age inclusive (Panels A through E) or from 60 to 79 years of age inclusive (Panels F through J)
  • * Has a history of myocarditis, pericarditis, and/or myopericarditis
  • * Has a history of cancer

Ages Eligible for Study

18 Years to 79 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Merck Sharp & Dohme LLC,

Medical Director, STUDY_DIRECTOR, Merck Sharp & Dohme LLC

Study Record Dates

2027-01-17